TNGXTango Therapeutics, Inc.
$23.82+213% 1Y
$23.82
$6.9152 weeks$32.90
Is the price fair?
What TNGX's price assumes
Tango Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 78.7× revenue.
78.7
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 14.2
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 73.2
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 14.2
- EV / EBIToperating margin −228%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 73.2
- Market capitalisation
- $4.91B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks